U.S. markets close in 5 hours 2 minutes

  • S&P 500

    4,276.06
    -11.99 (-0.28%)
     

  • Dow 30

    33,333.62
    -173.88 (-0.52%)
     

  • Nasdaq

    13,265.36
    +46.04 (+0.35%)
     

  • Russell 2000

    1,764.96
    -20.14 (-1.13%)
     

  • Crude Oil

    88.92
    -1.87 (-2.06%)
     

  • Gold

    1,843.90
    -22.20 (-1.19%)
     

  • Silver

    21.47
    -0.99 (-4.39%)
     

  • EUR/USD

    1.0495
    -0.0080 (-0.76%)
     

  • 10-Yr Bond

    4.6740
    +0.1010 (+2.21%)
     

  • GBP/USD

    1.2117
    -0.0084 (-0.69%)
     

  • USD/JPY

    149.8300
    +0.5000 (+0.33%)
     

  • Bitcoin USD

    28,326.19
    +1,209.98 (+4.46%)
     

  • CMC Crypto 200

    605.94
    +2.40 (+0.40%)
     

  • FTSE 100

    7,496.92
    -111.16 (-1.46%)
     

  • Nikkei 225

    31,759.88
    -97.72 (-0.31%)
     

Johnson & Johnson gets partial win in patent appeal against Covidien

Reuters

By Andrew Chung

NEW YORK, Aug 7 (Reuters) - Johnson & Johnson subsidiary Ethicon Endo-Surgery Inc will get a second chance to hold rival surgical instrument maker Covidien Plc liable for allegedly infringing two patents on a specialized ultrasonic device that cuts and seals blood vessels.

The U.S. Court of Appeals for the Federal Circuit on Friday said a lower court should not have canceled one of the patents on Ethicon's surgical shears, and incorrectly ruled that Covidien did not infringe the other. The appeals court, however, upheld a ruling that Covidien did not copy the design of Ethicon's device.

(Reporting by Andrew Chung; Editing by Meredith Mazzilli)